Cited by 25Lymphoma Diagnosis and TreatmentT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes

Open access
Qiu, Zhijun, Khalife, Jihane, Ethiraj, Purushoth, Jaafar, Carine, Lin, An-Ping, Holder, Kenneth N., Ritter, Jacob P., Chiou, Lilly +8 more·2024·Science Advances

Published version of a preprint

Abstract

The mechanism by which interferon regulatory factor 8 (IRF8) mutation contributes to lymphomagenesis is unknown. We modeled IRF8 variants in B cell lymphomas and found that they affected the expression of regulators of antigen presentation. Expression of IRF8 mutants in murine B cell lymphomas suppressed CD4, but not CD8, activation elicited by antigen presentation and downmodulated CD74 and human leukocyte antigen (HLA) DM, intracellular regulators of antigen peptide processing/loading in the major histocompatibility complex (MHC) II. Concordantly, mutant IRF8 bound less efficiently to the promoters of these genes. Mice harboring IRF8 mutant lymphomas displayed higher tumor burden and remodeling of the tumor microenvironment, typified by depletion of CD4, CD8, and natural killer cells, increase in regulatory T cells and T follicular helper cells. Deconvolution of bulk RNA sequencing data from IRF8-mutant human diffuse large B cell lymphoma (DLBCL) recapitulated part of the immune remodeling detected in mice. We concluded that IRF8 mutations contribute to DLBCL biology by facilitating immune escape.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.adk2091

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Qiu, Z., Khalife, J., Ethiraj, P., Jaafar, C., Lin, A.-P., Holder, K. N., Ritter, J. P., Chiou, L., Huelgas-Morales, G., Aslam, S., Zhang, Z., Liu, Z., Arya, S., Gupta, Y. K., Dahia, P. L. M., & Aguiar, R. C. T.
Affiliations
  • The University of Texas at San Antonio Health Science Center (US)
  • Division of Hematology and Medical Oncology, Department of Medicine, Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
Corresponding author
  • Qiu, Zhijun
  • Khalife, Jihane
  • Ethiraj, Purushoth
  • Jaafar, Carine
  • Aguiar, Ricardo C.T.
Venue
Science Advances
Published
2024-07-12
Volume
10
Issue
28
Pages
eadk2091-eadk2091
ISSN
2375-2548 (ISSN-L)
OpenAlex
W4400578706
Cited by
25
References
7
Citations by year
2026: 13 · 2025: 11 · 2024: 1
FWCI
7.55
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01BX001882, IK6 BX006542)
  • Cancer Prevention and Research Institute of Texas (RP190043)
  • University of Texas System
  • Neuroendocrine Tumor Research Foundation
  • National Institutes of Health (5r01ca102031-12)
  • National Cancer Institute (P30CA054174, R01CA135332, R01CA095512, P50CA186781, R01CA264248)
  • National Institute of General Medical Sciences (R01GM140456, R01GM114102, R35GM153228)
  • National Institute of Allergy and Infectious Diseases (R01AI161363)
  • National Institute of Environmental Health Sciences (R01ES031522)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
B-cell lymphoma, diffuse large B-cell lymphoma, immune evasion, antigen processing and presentation, MHC class II, CD74, HLA-DM, tumor microenvironment remodeling, regulatory T cells, T follicular helper cells, natural killer cells, lymphomagenesis, transcriptional regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review